Rovalpituzumab - HY-P99043
Nur noch %1 verfügbar
Catalog #
HY-P99043
Ab
227,00 €
Rovalpituzumab is a humanized monoclonal antibody against delta-like protein 3 (DLL3). Rovalpituzumab can be used in the synthesis of antibody-drug conjugate (ADC), Rovalpituzumab Tesirine. Rovalpituzumab has activity against small cell lung cancer (SCLC)[1].
| Datasheet URL | http://file.medchemexpress.com/batch_PDF/HY-P99043/Rovalpituzumab-DataSheet-MedChemExpress.pdf |
|---|---|
| Shipping | Dry Ice |
| Application | Cancer-programmed cell death |
| Alternative Names | SC-0001 |
| CAS | 1613313-01-1 |
| Storage | Store at -80°C for 2 years |
| MWT | (145.02 kDa) |
| Solubility | H2O |
| Clinical Information | Phase 3 |
| Target | Notch |
| Application: | Cancer-programmed cell death |
|---|